Advisory Services Network’s TriSalus Life Sciences TLSI Stock Holding History

Advisory Services Network’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$28	–	4406
2026 Q1	$28	Buy	+7	New	+$34	﹤0.01%	4799
2025 Q4	–	Sell	-7	Closed	-$33	–	4037
2025 Q3	$33	Buy	+7	New	+$33	﹤0.01%	4483

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Advisory Services Network's TLSI Position: Q2 2026 in Review

Advisory Services Network sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 7 shares — an estimated $28 sold.

Advisory Services Network first reported a position in TLSI in Q3 2025 and held it in 2 quarters. The position peaked at $33 in Q3 2025. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Advisory Services Network reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 7 TriSalus Life Sciences shares in Q2 2026, an estimated $28.
Advisory Services Network first reported a position in TriSalus Life Sciences in Q3 2025 and held it in 2 quarters.
Advisory Services Network's TriSalus Life Sciences position peaked at $33 in Q3 2025.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.